Commercial launch is on-track for ZUSDURI™, the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk ...
Discover how to access company financial reports and SEC filings through investor relations sections and the EDGAR database ...
As of January 2026, the overall advertised street rate declined 0.2 percent year-over-year to $16.27 for the combined mix of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results